Everolimus in Combination With DHAP in Patients With Relapsed or Refractory Hodgkin Lymphoma
Clinical trial NCT01453504 · COMPLETED
Trial details
- NCT number
- NCT01453504
- Sponsor
- University of Cologne
- Status
- COMPLETED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2012-08-01
- Primary completion
- 2019-03-01
- Enrollment
- 73
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.